Targeting macrophages using anti-CSF-1R antibody or clodrolip (clodronate encapsulated liposomes) also impaired chronic lymphocytic leukemia cell engraftment. The gene discussed is CSF1R; the disease is B-cell chronic lymphocytic leukemia.